Alzheimer's disease vaccine (Axon Neuroscience)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameAlzheimer's disease vaccine (Axon Neuroscience)
Drug Alias NameAxon peptide 108 conjugated to KLH阿尔茨海默病疫苗 - Axon NeuroscienceAxon peptide 108 coupled to KLHAADvac-1
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionMicrotubule-associated protein tau modulatorsImmunostimulants
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsPrimary Progressive Nonfluent AphasiaAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSlovakiaSweden +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAxon Biochemicals
China Registration ClassN/A

Develop Information

Active CompaniesAlzheimer'S Therapeutic Research InstituteAlzheimer'S Clinical Trials ConsortiumAxon Neuroscience Se +[8] 
Inactive CompaniesN/A
Active IndicationsSupranuclear Palsy, Progressive
Inactive IndicationsPrimary Progressive Nonfluent AphasiaAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A